GTG hails successful year despite mixed results

By Dylan Bushell-Embling
Wednesday, 03 September, 2008


Genetic Technologies [ASX: GTG] has reported what company representatives believe to be positive financial year results, even though it experienced a consolidated loss of over $5 million.

Consolidated loss after tax for FY08 was up 25 per cent to $5.4 million, despite a five per cent increase in revenue to $15.7 million and positive net cash flows from operations.

As a result of this loss, the company has no plans to pay share dividends, and the company's consolidated net tangible assets have decreased from four to 3.83 cents per share.

According to GTG, these losses resulted from amortisation of patents, impairment losses, depreciation of plant and equipment, foreign exchange losses and share-based payment expenses.

Over the period, GTG also acquired the Frozen Puppies Dot Com business and a 15 per cent stake in a mining venture.

The company also continued to develop products which are coming closer to commercialisation, it said.

Related Articles

Fetuses can fight infections within the womb

A fetus has a functional immune system that is well-equipped to combat infections in its...

Gene therapy reverses heart failure in large animal model

The therapy increases the amount of blood the heart can pump and dramatically improves survival,...

Meditation to reduce pain is not a placebo — it's real

Mindfulness meditation has long been speculated to work by activating processes supporting the...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd